Dyne Therapeutics Inc (DYN NASDAQ) stock market data APIs
$20.6378
-0.69(-3.3%)
as of December 4, 2025
Try our APIs with
free plan!
Dyne Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Prev. Close
20.6378
Open
19.9452
High
21.2353
Low
19.5513
52 wk Range
6.36-29.715
Market Cap
2 949 M
Shares Outstanding
143 M
EPS
-0.76
Beta
1.298
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Dyne Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Dyne Therapeutics Inc data using free add-ons & libraries
Get Dyne Therapeutics Inc Fundamental Data
Dyne Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -447 184 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-04
- EPS/Forecast: -0.8398
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Dyne Therapeutics Inc News
New
After-Hours Biotech Rally: Clene Surges Ahead Of ALS Update; Werewolf, Biomea, Dyne Also Climb
(RTTNews) - Several biotech and therapeutics companies posted notable gains in after-hours trading on Tuesday, December 2, 2025, following a mix of corporate updates, investor anticipation, and recent...
Bernstein Sees Favorable Risk-Reward for Dyne Therapeutics (DYN) Ahead of Major DYN-251 Data Release
Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the best upside stocks to buy now. On November 25, Bernstein raised the firm’s price target on Dyne Therapeutics to $21 from $12 with a Market Perform r...
Why Dyne Therapeutics Stock Was Crushing it This Week
Key Points It was mentioned positively in a new analyst note on the biotech sector. The researchers feel a recent rally in such titles somewhat unfairly left it behind. 10 stocks we like better than ...
Dyne Therapeutics, Inc. Loss At -$108.14 Mln In Q3
(RTTNews) - Dyne Therapeutics, Inc. (DYN) revealed Loss for third quarter of -$108.14 million The company's earnings came in at -$108.14 million, or -$0.76 per share. This compares with -$97.12 mill...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
